Reports for APO-RIVASTIGMINE
Brand name APO-RIVASTIGMINE |
|---|
Company Name
APOTEX INC
|
Drug Identification Number
02336731 |
Ingredients
RIVASTIGMINE |
Ingredient Strength
4.5 MG |
ATC Code
N06DA |
ATC Descriptor
ANTI-DEMENTIA DRUGS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| APO-RIVASTIGMINE | 100 BTL | Resolved | 2017-03-11 | 2017-05-18 | 487 |
| APO-RIVASTIGMINE | 100 BTL | Resolved | 2018-01-22 | 2018-01-22 | 36947 |
| APO-RIVASTIGMINE | 100 BTL | Resolved | 2018-01-22 | 2018-03-27 | 36949 |
| APO-RIVASTIGMINE | 100 BTL | Resolved | 2019-06-05 | 2019-10-07 | 85610 |
| APO-RIVASTIGMINE | 100 BTL | Actual shortage | 2025-01-23 | 2025-02-06 | 248492 |
Showing 1 to 5 of 5
Discontinuation reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0